Patrick Heron, Director at Tobira Therapeutics, holds 8.82M shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 3.73M shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 2.31M shares in Imago BioSciences (Ticker: IMGO). Most recently, Patrick Heron Bought ― shares of Arcutis Biotherapeutics on Mar 06, 2024 for an estimated value of 199.99K.
Patrick Heron latest transaction was an Informative Buy of $199.99K.
What was Patrick Heron's most profitable transaction?
Patrick Heron’s most profitable transaction was an Informative Buy of MIRM stock on July 24, 2019. The return on the trade was 47.80%.
What is Patrick Heron's role in Tobira Therapeutics?
Patrick Heron's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.